Compared to female breast cancer, IGF1-R was more frequently expressed in male breast cancer (p<0.001), while MET and FGFR2 were less frequently expressed (both p<0.001; Table 2) in male breast cancer. The gene discussed is IGF1R; the disease is breast carcinoma.